Published in Ann Surg on March 01, 1983
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg (1989) 2.79
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69
Personal experience with 411 hepatic resections. Ann Surg (1988) 2.46
Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg (1989) 2.40
Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg (1984) 2.06
Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92
Major hepatic resection for metachronous metastases from colon cancer. Ann Surg (1985) 1.89
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg (1985) 1.65
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg (1988) 1.61
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46
Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg (1988) 1.33
Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg (1994) 1.32
Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet (1990) 1.31
A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg (1984) 1.30
Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology (1990) 1.24
Intraperitoneal septic complications after hepatectomy. Ann Surg (1986) 1.22
Elective and emergency hepatic resection. Determinants of operative mortality and morbidity. Ann Surg (1991) 1.21
Large hepatocellular cancers: hepatic resection or liver transplantation? Br Med J (Clin Res Ed) (1985) 1.19
One hundred hepatic resections. Indications and operative results. Ann Surg (1985) 1.14
Accuracy of computerized tomography in determining hepatic tumor size in patients receiving liver transplantation or resection. J Clin Oncol (1984) 1.13
Liver transplantation for malignant tumors. Gastroenterol Clin North Am (1988) 1.09
Complications in 100 living-liver donors. Ann Surg (1998) 1.07
Intra-abdominal sepsis after hepatic resection. Ann Surg (1989) 1.07
The changing face of hepatic resection. Curr Probl Surg (1989) 0.96
Preoperative imaging of liver metastases. Comparison of angiography, CT scan, and ultrasonography. Ann Surg (1985) 0.93
Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Korean J Radiol (2003) 0.88
Liver resection for hepatocellular carcinoma: results from 150 consecutive patients. Cancer Chemother Pharmacol (1989) 0.87
Hepatic resections for primary liver cancer. Cancer Chemother Pharmacol (1994) 0.87
Has laparoscopy increased surgical indications for benign tumors of the liver? Langenbecks Arch Surg (2012) 0.87
Experience with resection of primary hepatic malignancy. Surg Clin North Am (1989) 0.82
Scoring of prognostic factors that influence long-term survival in patients with hepatic metastasis of colorectal cancer. Korean J Hepatobiliary Pancreat Surg (2011) 0.79
Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component. Br J Cancer (1987) 0.79
Effect of gene therapy with the herpes simplex virus-thymidine kinase gene on hepatic metastasis in murine colon cancer. Surg Today (1997) 0.77
Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc (1991) 0.75
Primary hepatocellular carcinoma--recent advances and future prospects. West J Med (1985) 0.75
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg (1976) 2.96
Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80
Results in 107 hepatic lobectomies with a preliminary report on the use of a clamp to reduce blood loss. Ann Surg (1973) 2.77
Survival after liver resection for secondary tumors. Am J Surg (1978) 2.57
Major hepatic resections for metastatic colorectal cancer. Ann Surg (1980) 2.41
Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg (1975) 1.72
The seventies evolution in liver surgery for cancer. Cancer (1981) 1.68
Elective hepatic surgery. Ann Surg (1974) 1.66
The surgical management of primary carcinoma of the liver. World J Surg (1982) 1.64
Survival after liver resection for cancer. Cancer (1970) 1.40
Excisional treatment of cavernous hemangioma of the liver. Ann Surg (1980) 1.37
Resection of primary solid hepatic tumors. Am J Surg (1981) 1.34
Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgery. World J Surg (1982) 1.30
Hepatic resection. Pillars of success built on the foundation of 15 years of experience. Am J Surg (1981) 1.26
Hepatic resection for malignant tumors of the liver: essentials for a unified surgical approach. Am J Surg (1980) 1.14
Recent advances in technique of hepatic lobectomy and results of surgical treatment for primary carcinoma of the liver. Prog Liver Dis (1976) 1.11
Liver resection for hepatic adenoma. Arch Surg (1979) 1.09
Primary carcinoma of the liver: improvement in sight? World J Surg (1982) 1.07
Liver resection for cancer. Acta Chir Scand (1976) 1.00
Primary hepatic carcinoma resection over 18 years. Chin Med J (Engl) (1980) 0.99
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01